New treatment option for Chronic Post-surgical Pain
Official title Radiofrequency Ablation for the Treatment of Post-knee Arthroplasty Chronic Pain.
ClinicalTrials.gov ID: NCT05920382
What this study is testing
- What it's testing
- Knee osteoarthritis pain is one of the conditions commonly seen in general and specialized medicine. Knee arthroplasty is one of the most successful orthopedic surgeries for the treatment of this disease, significantly improving pain, disability, and the overall quality of life for patients who undergo it.
- Time commitment: about 10 years
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Individuals who have undergone knee arthroplasty.
- Chronic knee pain post-knee arthroplasty for at least 6 months after the procedure and less than 5 years.
- Pain intensity on the numerical visual scale ≥ 5 out of 10 points.
- Stable pain for the last 30 days.
- The knee is the location with the highest intensity of pain, in the case of patients with multiple joint pains.
You likely can't join if
- Acute knee pain.
- Psychiatric illness or dementia that may interfere with or hinder study assessments.
- Diagnosis of fibromyalgia, chronic fatigue syndrome, or central sensitization syndrome.
- Knee infiltration with corticosteroids in the past 30 days.
- Changes in oral analgesic medication in the past 30 days.
The study team makes the final eligibility decision.
Where it's taking place
- Barcelona, Catalonia, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 10 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Barcelona, Catalonia, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.